Your browser doesn't support javascript.
loading
Immuno-genomic-radiomics to predict response of biliary tract cancer to camrelizumab plus GEMOX in a single-arm phase II trial.
Liu, Qiu-Ping; Tang, Jie; Chen, Yi-Zhang; Guo, Fen; Ma, Ling; Pan, Lan-Lan; Tian, Yi-Tong; Wu, Xiao-Feng; Zhang, Yu-Dong; Chen, Xiao-Feng.
Afiliación
  • Liu QP; Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China.
  • Tang J; Department of Oncology, Liyang People's Hospital, Liyang, China.
  • Chen YZ; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Guo F; Department of Oncology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, China.
  • Ma L; Gusu School, Nanjing Medical University, Suzhou, China.
  • Pan LL; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Tian YT; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Wu XF; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Zhang YD; Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Chen XF; Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China.
JHEP Rep ; 5(7): 100763, 2023 Jul.
Article en En | MEDLINE | ID: mdl-37333974
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: JHEP Rep Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: JHEP Rep Año: 2023 Tipo del documento: Article País de afiliación: China